Sameer Farouk Sait, MBBS
Pediatric Brain and Spinal Cord Tumors, Neurofibromatosis Type 1 and Rasopathies, Adolescent and Young Adult Oncology, Molecular Targeted Therapies and Combinations with Immunotherapies, Radio-Immunotherapy
We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
New Patient Appointments
Scheduling a visit is easy. Click below or call us to get started.
Dr. Sait accepts the following list of insurance providers. Select your insurance provider to see more details.
Memorial Sloan Kettering is an in-network provider with Aetna HMO, POS, and PPO plans. Aetna does not include us in any of the plans you can purchase through the insurance exchanges or through Medicare. Please ask your insurance if you need a one-time referral. MSK has an agreement with the Aetna Transplant Program for all Aetna's commercial products.
Memorial Sloan Kettering is a designated Blue Distinction Center for bone marrow transplant and CAR-T.
We understand that there may be many complexities involved with insurance coverage purchased through the health exchange network of the Affordable Care Act. We’re here to help. If you have questions about how your care will be covered by an insurance provider, or need help navigating a change in coverage, please call us at 646-227-3378; if you are not a resident of New York, you can call us at 866-248-1274. Our team is here to listen to your concerns and assist you in any way we can. We want our care to be as accessible and affordable for as many people as possible.
Memorial Sloan Kettering is an in-network provider with CIGNA's HMO, POS, and PPO plans. CIGNA does not include us in any of the plans you can buy through the insurance exchanges.
- If you are a New York State resident: Please ask your insurance if you need a one-time referral.
- If you live outside of New York State: Please ask your insurance if you have in-network access to Memorial Sloan Kettering.
Memorial Sloan Kettering is an in-network provider with EmblemHealth’s PPO, EPO, POS, HMO plans. EmblemHealth includes GHI, HIP, Vytra, and ConnecticCare (in NYS Only). You must bring a referral from your Emblem primary care doctor to your first appointment. In-network participation exceptions include:
- Emblem’s HIP Commercial Millennium, Select Care and Enhanced Care Prime networks is not in-network with Memorial Sloan Kettering.
- Please call Emblem to confirm if your specific plan is in-network.
For information regarding Memorial Sloan Kettering’s participation with Emblem’s Medicare Advantage Plans, please refer to the Medicare & Medicaid page
Memorial Sloan Kettering is an in-network provider with Empire Blue Cross Blue Shield (Wellpoint) of New York Indemnity, HMO, EPO, PPO, POS and Medicare Advantage plans, with the following exceptions:
- Empire Blue Cross Blue Shield does not include us in any of the plans you can buy through the insurance exchanges.
- Please call Empire BCBS to confirm if your specific plan is in-network with Memorial Sloan Kettering.
Memorial Sloan Kettering is an in-network provider with HealthFirst’s commercial products; these commercial products are not purchased on the insurance exchanges.
Memorial Sloan Kettering is an in-network provider with HealthSmart’s Accel, HSPC, and HPO networks.
For our NJ locations, Memorial Sloan Kettering is an in-network provider with most Horizon Blue Cross Blue Shield of New Jersey plans for individuals, families, and small businesses. Horizon members with Blue Card Access (there would be a suitcase logo on the front of the card) may have access to our NY locations. Please call Horizon to confirm if your plan is in-network in NY.
Memorial Sloan Kettering is a designated Center of Excellence by Humana.
Memorial Sloan Kettering is a designated Center of Excellence by Interlink Health Services.
Memorial Sloan Kettering is a designated Center of Excellence by Lifetrac.
Memorial Sloan Kettering is an in-network provider for all MagnaCare health plans except those products you can buy through the insurance exchanges.
For information about Medicare and Medicaid, please visit this page
Memorial Sloan Kettering is an in-network provider with some Multiplan/Beech Street/PHCS plans. Contact your insurance carrier to find out if your plan provides in-network access to Memorial Sloan Kettering.
Memorial Sloan Kettering is a designated Center of Excellence by Multiplan.
If you are covered by more than one insurance plan, you will want to determine your benefits from both plans. First, you need to determine which one is your primary insurance provider by contacting your employee benefits office or your insurance carriers. After you find out which is your primary insurance provider, you should then contact your insurance carrier to determine if you have access to Memorial Sloan Kettering.
Memorial Sloan Kettering is an in-network provider with some MVP plans. Contact your insurance carrier to find out if your plan provides in-network access to Memorial Sloan Kettering.
Memorial Sloan Kettering is an in-network provider for New York State employees who have enrolled in UnitedHealthcare's Cancer Resource Services. If you have the Empire Plan, you should call Cancer Resources Services at 866-936-6002 to verify and enroll in this coverage.
Memorial Sloan Kettering is in-network with Oscar’s Circle Plus Network, a part of its Small Group Broad line that is offered only to select small business groups. Oscar does not include Memorial Sloan Kettering as an in-network provider for any of its individual plans. Please confirm eligibility with your insurance carrier.
Most Blue Cross Blue Shield plans include Memorial Sloan Kettering as an in-network provider. Contact your insurance company to confirm if Memorial Sloan Kettering is in-network.
We have agreements with several insurance companies that may provide additional coverage for cancer patients. These benefit programs include:
- AXA Assistance USA
- Beech Street
- Integrated Health Plans
- National Health Administrators
- National Preferred Provider Network
- UnitedHealthcare's Cancer Resource Services
- United Resource Network
- Veterans Choice Program
Memorial Sloan Kettering is an in-network provider with Oxford’s Freedom and Liberty plans as well as the Metro Plan (which is only offered to small business groups and no longer offered as individual plans). Please confirm with your insurance if you need a one-time referral. Note: Oxford’s Medicare Managed Care plan — Secure Horizon — does not include Memorial Sloan Kettering as an in-network provider. Oxford does not include us in any of the plans you can buy through the insurance exchanges.
Memorial Sloan Kettering is an in-network provider with the World Trade Center Health Program.
Memorial Sloan Kettering is an in-network provider with QualCare's PPO and HMO/POS network.
Memorial Sloan Kettering is a designated Center of Excellence by Specialty Care Management.
Hospital and physician services may be covered by TRICARE. Please call your TRICARE plan to confirm coverage at Memorial Sloan Kettering.
Memorial Sloan Kettering is an in-network provider with UnitedHealthCare's HMO, POS, and PPO plans. Please confirm with your insurance if a one-time referral is needed.
UnitedHealthCare's Medicare Managed Care plan does not include Memorial Sloan Kettering as an in-network provider.
United does not include us in any of the plans you can buy through the insurance exchanges.
Memorial Sloan Kettering is a designated Center of Excellence by UnitedHealthcare.
Contact and Location
Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offer many services, including screening, chemotherapy, and medical testing.
MBBS, Kasturba Medical College (2004-2010)
General Pediatrics - Saint Peter’s University Hospital (2012-2015)
Pediatric Hematology/Oncology - Memorial Sloan Kettering Cancer Center (2015-2018)
American Board of Pediatrics - American Board of Pediatric Hematology/Oncology
I am a pediatric oncologist on the MSK Kids team who specializes in the treatment of pediatric brain tumors, including low-grade and high-grade gliomas, embryonal tumors like medulloblastoma, and ependymoma. I have a special interest in treating adolescents and young adults with these cancers. I also care for patients with neurofibromatosis type 1 (NF1) and its associated cancer-related conditions — including plexiform neurofibromas, malignant peripheral nerve sheath tumors (MPNSTs), and high-grade gliomas — as well as non-cancer-related issues. At Memorial Sloan Kettering Cancer Center (MSK), I work with a multidisciplinary team to offer comprehensive care, which is critical for patients with NF1.
In my research, I explore the molecular drivers of brain tumors, with the goal of identifying new targets that can be used to develop innovative targeted therapies. My colleagues and I look at how using different anti-cancer drugs individually and in combination affects tumor growth and resistance to therapy, including the influence of immature cells called stem cells. We also study the use of radioimmunotherapy (radiation therapy given with immunotherapy to precisely target brain cancer cells while sparing nearby normal healthy tissues).
I work closely with the Brain Tumor Center, led by developmental biologist Luis Parada at the Sloan Kettering Institute, to conduct translational research to identify more effective combination treatments for children and adults with NF1 high-grade gliomas and MPNSTs. I am also a member of the Pediatric Translational Medicine Program. Our shared goal is to take findings from laboratory studies, translate them into early-phase clinical trials for young patients, and improve these patients’ quality of their care. I enjoy being able to conduct research at MSK, where there are excellent resources for investigators like myself, while caring for patients. It provides an opportunity to make a difference and improve the lives of these young patients.
Beyond these research endeavors, I also collaborate with the team in the MSK Kids Clinical Genetics Service and Pediatric Cancer Predisposition Screening Program. Here, patients and families benefit from genetic counseling and testing for cancer predisposition syndromes like NF1. We’re starting to perform more sophisticated molecular testing in patients, such as testing for DNA fragments shed in the blood (circulating cell-free DNA), to not only detect cancer but also to understand why some people develop cancer. This may eventually lead to prevention, earlier intervention, and cures. There are also many exciting developments and specific drug treatments that have recently emerged for people with these cancer predisposition syndromes.
What I find most gratifying about my work is being able to apply the scientific knowledge I’ve acquired, offer patients innovative and less toxic treatments when feasible, and see these efforts benefit my patients. I was attracted to the field of pediatric neuro-oncology because I felt like there was a lot of room to improve the treatment that we use to care for patients with these cancers, especially given how prevalent they are in this patient population. Brain tumors are the second most common form of cancer in children, after leukemia.
When I meet an adolescent or young adult with cancer, I individualize the experience for them and try to make them feel empowered. Just as each person’s cancer has different or distinctive genetic changes, every person I care for is also unique. Beyond personalized care, it is also important to me to give patients the opportunity to express their concerns and ask any questions that they may have so I can alleviate their anxieties.
Cancer care for this age group is sometimes fragmented. Whereas some patients receive care from MSK’s pediatric oncologists, others will work with our medical oncologists. We have a special program here at MSK to ensure that patients in this age group receive seamless care.
Awards and Honors
- K12 Paul Calabrese Career Development Award in Clinical Oncology – Research Scholar (2018-2021)
- Career Development Award – Developmental and Hyperactive RAS Tumor SPORE (2015-2021)
- Matthew Larson Foundation grant for Pediatric Brain Tumors (2022-2023)
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Research and Publications
Visit PubMed for a full listing of Dr. Sait’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
At MSK, we’re committed to delivering the best care to every patient. We use feedback from our patients to continue to improve our care. We also post patient reviews online to help you make healthcare choices. Learn more about our patient experience reviews.